Literature DB >> 20472805

The histopathologic and molecular basis for the diagnosis of histiocytic sarcoma and histiocyte-associated lymphoma of mice.

X Hao1, T N Fredrickson, S K Chattopadhyay, W Han, C-F Qi, Z Wang, J M Ward, J W Hartley, H C Morse.   

Abstract

Histiocytic sarcoma (HS) and histiocyte-associated lymphoma (HAL) of mice are difficult to distinguish histologically. Studies of multiple cases initially diagnosed as HS or HAL allowed us to define HS as round, fusiform, or mixed cell types that were F4/80+, Mac-2+, and PAX5-; that lacked markers for other sarcomas; and that had immune receptor genes in germline configuration. Two other subsets had clonal populations of lymphocytes. The first, HAL, featured malignant lymphocytes admixed with large populations of normal-appearing histiocytes. The second appeared to be composites of lymphoma and HS. Several cases suggestive of B myeloid-lineage plasticity were also observed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20472805      PMCID: PMC3407882          DOI: 10.1177/0300985810363705

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  53 in total

1.  Reversion of B cell commitment upon loss of Pax5 expression.

Authors:  Ingvild Mikkola; Barry Heavey; Markus Horcher; Meinrad Busslinger
Journal:  Science       Date:  2002-07-05       Impact factor: 47.728

Review 2.  Stability and plasticity of wild-type and Pax5-deficient precursor B cells.

Authors:  Antonius G Rolink; Christoph Schaniel; Fritz Melchers
Journal:  Immunol Rev       Date:  2002-09       Impact factor: 12.988

3.  T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells.

Authors:  Megan S Lim; Michael Beaty; Lynn Sorbara; Richard Z Cheng; Stefania Pittaluga; Mark Raffeld; Elaine S Jaffe
Journal:  Am J Surg Pathol       Date:  2002-11       Impact factor: 6.394

Review 4.  In vitro and in vivo plasticity of Pax5-deficient pre-B I cells.

Authors:  Antonius G Rolink; Christoph Schaniel; Ludovica Bruno; Fritz Melchers
Journal:  Immunol Lett       Date:  2002-06-03       Impact factor: 3.685

5.  Dysregulated TCL1 promotes multiple classes of mature B cell lymphoma.

Authors:  Katrina K Hoyer; Samuel W French; Devin E Turner; Mai T N Nguyen; Mathilde Renard; Cindy S Malone; Sonja Knoetig; Chen-Feng Qi; Thomas T Su; Hilde Cheroutre; Randolph Wall; David J Rawlings; Herbert C Morse; Michael A Teitell
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-14       Impact factor: 11.205

6.  Lymphomas and high-level expression of murine leukemia viruses in CFW mice.

Authors:  L Taddesse-Heath; S K Chattopadhyay; D L Dillehay; M R Lander; Z Nagashfar; H C Morse; J W Hartley
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

7.  T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: differential diagnosis from Hodgkin's lymphoma.

Authors:  M Fraga; L Sánchez-Verde; J Forteza; A García-Rivero; M A Piris
Journal:  Histopathology       Date:  2002-09       Impact factor: 5.087

8.  Bethesda proposals for classification of lymphoid neoplasms in mice.

Authors:  Herbert C Morse; Miriam R Anver; Torgny N Fredrickson; Diana C Haines; Alan W Harris; Nancy L Harris; Elaine S Jaffe; Scott C Kogan; Ian C M MacLennan; Paul K Pattengale; Jerrold M Ward
Journal:  Blood       Date:  2002-07-01       Impact factor: 22.113

9.  Genome-wide retroviral insertional tagging of genes involved in cancer in Cdkn2a-deficient mice.

Authors:  Anders H Lund; Geoffrey Turner; Alla Trubetskoy; Els Verhoeven; Ellen Wientjens; Danielle Hulsman; Robert Russell; Ronald A DePinho; Jack Lenz; Maarten van Lohuizen
Journal:  Nat Genet       Date:  2002-08-19       Impact factor: 38.330

10.  Inactivation of the F4/80 glycoprotein in the mouse germ line.

Authors:  Evelyne Schaller; Alison J Macfarlane; Rudolf A Rupec; Siamon Gordon; Andrew J McKnight; Klaus Pfeffer
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

View more
  17 in total

1.  MHC class I family proteins retard systemic lupus erythematosus autoimmunity and B cell lymphomagenesis.

Authors:  Caroline G McPhee; Thomas J Sproule; Dong-Mi Shin; Jason A Bubier; William H Schott; Martin P Steinbuck; Lia Avenesyan; Herbert C Morse; Derry C Roopenian
Journal:  J Immunol       Date:  2011-09-30       Impact factor: 5.422

Review 2.  Differentiation of rodent immune and hematopoietic system reactive lesions from neoplasias.

Authors:  Jerrold M Ward; Jerold E Rehg; Herbert C Morse
Journal:  Toxicol Pathol       Date:  2012-01-03       Impact factor: 1.902

Review 3.  Practical murine hematopathology: a comparative review and implications for research.

Authors:  Karyn E O'Connell; Amy M Mikkola; Aaron M Stepanek; Andyna Vernet; Christopher D Hall; Chia C Sun; Eda Yildirim; John F Staropoli; Jeannie T Lee; Diane E Brown
Journal:  Comp Med       Date:  2015-04       Impact factor: 0.982

4.  Histiocytic Sarcoma and Bilateral Facial Vein Thrombosis in a Siberian Hamster (Phodopus sungorus).

Authors:  Dondrae J Coble; Margaret Shoemaker; Bonnie Harrington; Adrienne D Dardenne; Brad Bolon
Journal:  Comp Med       Date:  2015-04       Impact factor: 0.982

5.  Immunohistochemical Characterization of Sarcomas in Trp53+/- Haploinsufficient Mice.

Authors:  M P Jokinen; D L Morgan; H C Price; R A Herbert; T Saddler; D Dixon
Journal:  Toxicol Pathol       Date:  2017-08       Impact factor: 1.902

6.  Myeloid cell TRAF3 regulates immune responses and inhibits inflammation and tumor development in mice.

Authors:  Almin I Lalani; Carissa R Moore; Chang Luo; Benjamin Z Kreider; Yan Liu; Herbert C Morse; Ping Xie
Journal:  J Immunol       Date:  2014-11-24       Impact factor: 5.422

Review 7.  Nonproliferative and proliferative lesions of the rat and mouse female reproductive system.

Authors:  Darlene Dixon; Roger Alison; Ute Bach; Karyn Colman; George L Foley; Johannes H Harleman; Richard Haworth; Ronald Herbert; Anke Heuser; Gerald Long; Michael Mirsky; Karen Regan; Eric Van Esch; F Russell Westwood; Justin Vidal; Midori Yoshida
Journal:  J Toxicol Pathol       Date:  2014       Impact factor: 1.628

8.  Immunophenotype of Spontaneous Hematolymphoid Tumors Occurring in Young and Aging Female CD-1 Mice. [Corrected].

Authors:  Jerold E Rehg; Richard Rahija; Dorothy Bush; Alys Bradley; Jerrold M Ward
Journal:  Toxicol Pathol       Date:  2015-07-28       Impact factor: 1.902

9.  IL-21-driven neoplasms in SJL mice mimic some key features of human angioimmunoblastic T-cell lymphoma.

Authors:  Shweta Jain; Jing Chen; Alina Nicolae; Hongsheng Wang; Dong-Mi Shin; Elisabeth B Adkins; Thomas J Sproule; Caroline M Leeth; Tomomi Sakai; Alexander L Kovalchuk; Mark Raffeld; Jerrold M Ward; Jerold E Rehg; Thomas A Waldmann; Elaine S Jaffe; Derry C Roopenian; Herbert C Morse
Journal:  Am J Pathol       Date:  2015-09-09       Impact factor: 4.307

10.  In Vivo Tumorigenesis, Osteolytic Sarcomas, and Tumorigenic Cell Lines from Transgenic Mice Expressing the Human T-Lymphotropic Virus Type 1 (HTLV-1) Tax Viral Oncogene.

Authors:  Lisa G Lanigan; Blake E Hildreth; Wessel P Dirksen; Jessica K Simmons; Chelsea K Martin; Jillian L Werbeck; Nandu K Thudi; Tracey L Papenfuss; Prosper N Boyaka; Ramiro E Toribio; Jerrold M Ward; Katherine N Weilbaecher; Thomas J Rosol
Journal:  Am J Pathol       Date:  2020-11-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.